Company
Headquarters: Changsha, China
Employees: 28,655
CN¥27.53 Billion
CNY as of Jan. 1, 2025
US$3.77 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥23.92 B |
| EBITDA | CN¥2.39 B |
| Gross Profit TTM | CN¥9.23 B |
| Profit Margin | 6.37% |
| Operating Margin | 9.64% |
| Quarterly Revenue Growth | 5.30% |
Yifeng Pharmacy Chain Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603939 wb_incandescent